Why is BioMark Diagnostics, Inc. ?
Unrated Stock - No Analysis Available
Quality key factors
Factor
Value
Sales Growth (5y)
-2.30%
EBIT Growth (5y)
-17.37%
EBIT to Interest (avg)
-1.85
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
-0.11
Tax Ratio
3.02%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
22.53
EV to EBIT
-14.32
EV to EBITDA
-18.49
EV to Capital Employed
-28.16
EV to Sales
28.16
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-139.55%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Technical Movement
4What is working for the Company
NET PROFIT(HY)
Higher at CAD -0.85 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -116.47 %
-7What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at CAD -1.09 MM
ROCE(HY)
Lowest at -340.71%
RAW MATERIAL COST(Y)
Grown by 212.78% (YoY
DEBTORS TURNOVER RATIO(HY)
Lowest at 1.51%
Here's what is working for BioMark Diagnostics, Inc.
Net Profit
Higher at CAD -0.85 MM
than preceding 12 month period ended Mar 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (CAD MM)
Debt-Equity Ratio
Lowest at -116.47 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for BioMark Diagnostics, Inc.
Operating Cash Flow
Lowest at CAD -1.09 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CAD MM)
Debtors Turnover Ratio
Lowest at 1.51%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 212.78% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






